Evidence map›Paper›PMID 27786478›Full record

ArticleJournal of the American Chemical Society2016

The Aggregation Free Energy Landscapes of Polyglutamine Repeats.

Mingchen Chen, MinYeh Tsai, Weihua Zheng, Peter G Wolynes

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Exploring the interplay between fibrillization and amorphous aggregation channels on the energy landscapes of tau repeat isoforms.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Review
  13. Disorder Mediated Oligomerization ofThe journal of physical chemistry. B · 2019
    Article
  14. Article
  15. Article
  16. Surveying the Energy Landscapes of Aβ Fibril Polymorphism.The journal of physical chemistry. B · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mingchen ChenCenter for Theoretical Biological Physics, ‡Department of Bioengineering, and §Department of Chemistry, Rice University , Houston, Texas 77005, United States.
MinYeh TsaiCenter for Theoretical Biological Physics, ‡Department of Bioengineering, and §Department of Chemistry, Rice University , Houston, Texas 77005, United States.
Weihua ZhengCenter for Theoretical Biological Physics, ‡Department of Bioengineering, and §Department of Chemistry, Rice University , Houston, Texas 77005, United States.
Peter G WolynesCenter for Theoretical Biological Physics, ‡Department of Bioengineering, and §Department of Chemistry, Rice University , Houston, Texas 77005, United States.

Funding

CONCEPTUAL ASPECTS OF THE PROTEIN FOLDING PROBLEMR01GM044557 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI WOLYNES, PETER GUY · 1990 to 2018
$4.2M
NIGMS NIH HHS R01 GM044557
6 · The paper itself

Abstract

Aggregates of proteins containing polyglutamine (polyQ) repeats are strongly associated with several neurodegenerative diseases. The length of the repeats correlates with the severity of the disease. Previous studies have shown that pure polyQ peptides aggregate by nucleated growth polymerization and that the size of the critical nucleus (n*) decreases from tetrameric to dimeric and monomeric as length increases from Q

Indexed as

Molecular Dynamics SimulationProtein AggregatesThermodynamicsPeptidesPeptidespolyglutamineProtein Aggregates

Identifiers

PMID27786478
PMCPMC5803750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.